USFDA approves Pfizer’s ZAVZPRET nasal spray for migraines
USFDA approves Pfizer's ZAVZPRET nasal spray for migraines. ZAVZPRET is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal sprayfor the acute treatment of migraine in adults.